Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% EBIT per Share is $-0.02 as of Apr. 2026. The stock has 5 warning signs investors should review. Among 1,584 Consumer Packaged Goods companies, PURE Bioscience ranks better than 66.98% on this metric.
PURE Bioscience's EBIT per Share for the
three
months ended in Apr. 2026 was $-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 19.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for PURE Bioscience's EBIT per Share or its related term are showing as below:
PURE'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.6 Med: 18.2 Max: 50.2
Current: 19.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PURE Bioscience was 50.20% per year. The lowest was -19.60% per year. And the median was 18.20% per year.
PURE's 3-Year EBIT Growth Rate is ranked better than 66.98% of 1584
companies
in the Consumer Packaged Goods industry
Industry Median: 7
vs PURE: 19.30
PURE Bioscience's EBIT for the
three
months ended in Apr. 2026 was $-0.52 Mil.
PURE Bioscience (OTCPK:PURE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
PURE Bioscience EBIT per Share Related Terms
PURE Bioscience EBIT per Share Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience (PURE) has a EBIT per Share of $-0.02 as of Apr. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PURE Bioscience and its competitors. According to the industry distribution chart, PURE Bioscience ranks #523 out of 1584 companies in the Consumer Packaged Goods industry, placing it in the top 33%.
Is PURE Bioscience's EBIT per Share too high?
PURE Bioscience's current EBIT per Share is $-0.02. Based on the distribution chart, PURE Bioscience ranks #523 out of 1584 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does PURE Bioscience's EBIT per Share compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #523 out of 1584 companies for EBIT per Share. This puts PURE Bioscience in the upper half of its industry. The industry median EBIT per Share is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 7.00, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current EBIT per Share is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current EBIT per Share is $-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For PURE Bioscience (PURE), the current EBIT per Share is $-0.02 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
